MBD3

Information MBD3

Description

DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. This gene belongs to a family of nuclear proteins which are characterized by the presence of a methyl-CpG binding domain (MBD). The encoded protein is a subunit of the NuRD, a multisubunit complex containing nucleosome remodeling and histone deacetylase activities. Unlike the other family members, the encoded protein is not capable of binding to methylated DNA. The protein mediates the association of metastasis-associated protein 2 with the core histone deacetylase complex. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]

Full Name

methyl-CpG binding domain protein 3

Source NCBI

ReMap Statistics

Datasets
2
Biotypes
2
Peaks
19,815
Non-redundant peaks
19,815

TF Classification

Super Class
Unknown
Class
Unknown
Familly
Unknown
Sub Familly
Unknown

Source TFClass

External IDs

JASPAR
Ensembl
ENSG00000071655
UniProt
O95983
Genevisible
O95983
RefSeq
NM_001281453
Aliases
All peaks MBD3
Download BED file
Non redundant peaks MBD3
Download BED file
SEQUENCES MBD3
Download FASTA file
DOWNLOAD All ReMap
Got to catalogue

Datasets Table for MBD3

Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks
MBD3 HeLa GEO Homo sapiens GSE41006 37
MBD3 MCF-7 GEO Homo sapiens GSE44737 19,778
Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.